Eli Lilly sales and marketing update

LLY launched its Cymbalta duloxetine to treat major depression in the U.S. Cymbalta, an oral serotonin (5-HT) and norepinephrine reuptake inhibitor, is marketed by LLY and partner Boehringer Ingelhei...